We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Xenetic Biosciences Inc is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The company is initially advancing cell-based therapeutics targeting B-cell receptor on the surface of an individual ... Xenetic Biosciences Inc is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The company is initially advancing cell-based therapeutics targeting B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. XCART has the potential to fuel a pipeline of therapeutic assets targeting oncology indications. It also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin resistant endometrial cancer. Show more
false 0001534525 0001534525 2024-02-12 2024-02-12 0001534525 XBIO:CommonStock0.001ParValuePerShareMember 2024-02-12 2024-02-12...
SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...
SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...
SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...
SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...
SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange...
false 0001534525 0001534525 2023-12-06 2023-12-06 0001534525 XBIO:CommonStock0.001ParValuePerShareMember 2023-12-06 2023-12-06...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.27 | -6.35294117647 | 4.25 | 4.25 | 3.65 | 8651 | 3.9359637 | CS |
4 | 0.19 | 5.01319261214 | 3.79 | 4.49 | 3.65 | 7333 | 4.12609655 | CS |
12 | 0.6 | 17.7514792899 | 3.38 | 4.49 | 3.07 | 5412 | 3.89186782 | CS |
26 | -1.95 | -32.8836424958 | 5.93 | 5.93 | 2.8696 | 4810 | 3.78671607 | CS |
52 | -0.32 | -7.44186046512 | 4.3 | 5.97 | 2.55 | 15882 | 3.80291657 | CS |
156 | -20.12 | -83.4854771784 | 24.1 | 56.8 | 2.40101 | 947537 | 29.39290691 | CS |
260 | -14.92 | -78.9417989418 | 18.9 | 152.5 | 2.40101 | 890587 | 27.2851491 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions